- Exchange: Tokyo
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Takeda Pharmaceutical Co Ltd
Add to Portfolio4502:JP
3,300 JPY 75 2.33%As of 02:00:00 ET on 05/25/2012.
Income Statement for Takeda Pharmaceutical Co Ltd (4502)
| All Values in Millions JPY (except Per Share) | FH2 2012 | FH1 2012 | FH2 2011 | FH1 2011 |
|---|---|---|---|---|
| Period End Date | 3/31/2012 | 9/30/2011 | 3/31/2011 | 9/30/2010 |
| Total Operating Revenue (Japan) | 806,430.00 | 702,502.00 | 705,360.00 | 714,025.00 |
| Revenue | 806,430.00 | 702,502.00 | 705,360.00 | 714,025.00 |
| - Cost of Revenue | 273,629.00 | 159,565.00 | 166,999.00 | 150,583.00 |
| Gross Profit | 532,801.00 | 542,937.00 | 538,361.00 | 563,442.00 |
| + Other Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| - Operating Expenses | 478,820.00 | 331,891.00 | 392,896.00 | 341,823.00 |
| Operating Income | 53,981.00 | 211,046.00 | 145,465.00 | 221,619.00 |
| - Interest Expense | 1,276.00 | 607.00 | 669.00 | 666.00 |
| - Foreign Exchange Losses (Gains) | -5,690.00 | 8,072.00 | -3,540.00 | -1,049.00 |
| - Net Non-Operating Losses (Gains) | 15,468.00 | -7,184.00 | 2,236.00 | -3,471.00 |
| Pretax Income | 42,927.00 | 209,551.00 | 146,100.00 | 225,473.00 |
| - Income Tax Expense | 53,102.00 | 72,105.00 | 41,512.00 | 79,814.00 |
| Income Before XO Items | -10,175.00 | 137,446.00 | 104,588.00 | 145,659.00 |
| - Extraordinary Loss Net of Tax | 0.00 | 0.00 | 0.00 | 0.00 |
| - Minority Interests | 1,323.00 | 1,786.00 | 931.00 | 1,448.00 |
| Net Income | -11,498.00 | 135,660.00 | 103,657.00 | 144,211.00 |
| - Total Cash Preferred Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| - Other Adjustments | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Inc Avail to Common Shareholders | -11,498.00 | 135,660.00 | 103,657.00 | 144,211.00 |
| Normalized Income | -11,498.00 | 135,660.00 | 103,657.00 | 144,211.00 |
| Basic EPS Before Abnormal Items | N/A | 171.85 | N/A | 182.69 |
| Basic EPS Before XO Items | -14.57 | 171.85 | 131.32 | 182.69 |
| Basic EPS | -14.57 | 171.85 | 131.32 | 182.69 |
| Basic Weighted Avg Shares | 789.41 | 789.39 | 789.37 | 789.38 |
| Diluted EPS | N/A | 171.83 | N/A | 182.66 |
| Diluted Weighted Avg Shares | N/A | 789.51 | N/A | 789.52 |
| All Values in Millions JPY (except Per Share) | FY 2012 | FY 2011 |
|---|---|---|
| Period End Date | 3/31/2012 | 3/31/2011 |
| Total Operating Revenue (Japan) | 1,508,932.00 | 1,419,385.00 |
| Revenue | 1,508,932.00 | 1,419,385.00 |
| - Cost of Revenue | 433,194.00 | 317,582.00 |
| Gross Profit | 1,075,738.00 | 1,101,803.00 |
| + Other Operating Revenue | 0.00 | 0.00 |
| - Operating Expenses | 810,711.00 | 734,719.00 |
| Operating Income | 265,027.00 | 367,084.00 |
| - Interest Expense | 1,883.00 | 1,335.00 |
| - Foreign Exchange Losses (Gains) | 2,382.00 | -4,589.00 |
| - Net Non-Operating Losses (Gains) | 8,284.00 | -1,235.00 |
| Pretax Income | 252,478.00 | 371,573.00 |
| - Income Tax Expense | 125,207.00 | 121,326.00 |
| Income Before XO Items | 127,271.00 | 250,247.00 |
| - Extraordinary Loss Net of Tax | 0.00 | 0.00 |
| - Minority Interests | 3,109.00 | 2,379.00 |
| Net Income | 124,162.00 | 247,868.00 |
| - Total Cash Preferred Dividends | 0.00 | 0.00 |
| - Other Adjustments | 0.00 | 0.00 |
| Net Inc Avail to Common Shareholders | 124,162.00 | 247,868.00 |
| One time charges(G) | 17,893.00 | 2,518.00 |
| Tax Effect on Abnormal Items | -8,873.36 | -823.39 |
| Normalized Income | 133,181.64 | 249,562.61 |
| Basic EPS Before Abnormal Items | 168.71 | 316.15 |
| Basic EPS Before XO Items | 157.29 | 314.01 |
| Basic EPS | 157.29 | 314.01 |
| Basic Weighted Avg Shares | 789.40 | 789.38 |
| Diluted EPS | 157.26 | 313.94 |
| Diluted Weighted Avg Shares | 789.53 | 789.53 |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Advertisements
Rate this Page